Search


Current filters:



Start a new search
Add filters:

Use filters to refine the search results.


Results 1-9 of 9
  • previous
  • 1
  • next
Item hits:
Issue DateTitleAuthor(s)
20-Aug-2016ICEC0942, an orally bioavailable selective inhibitor of CDK7 for breast cancerAli, S; Patel, H; Periyasamy, M; Bondke, A; Slafer, BW, et al
17-Oct-2016Genomic modelling of the ESR1 Y537S mutation for evaluating function and new therapeutic approaches for metastatic breast cancerHarrod, A; Fulton, J; Nguyen, VTM; Periyasamy, M; Ramos Garcia, L, et al
28-Aug-2015Expression profiling of nuclear receptors in breast cancer identifies TLX as a mediator of growth and invasion in triple-negative breast cancerLin, M-L; Patel, H; Remenyi, J; Banerji, CRS; Lai, C-F, et al
27-Nov-2015Differential epigenetic reprogramming in response to specific endocrine therapies promotes cholesterol biosynthesis and cellular invasionNguyen, VTM; Barozzi, I; Faronato, M; Lombardo, Y; Steel, JH, et al
14-Jun-2016CDK7, cyclin H and MAT1 is elevated in breast cancer and is prognostic in estrogen receptor- positive breast cancerPatel, H; Abduljabbar, R; Lai, CF; Periyasamy, M; Harrod, A, et al
24-Sep-2015APOBEC3B mediated cytidine deamination is required for estrogen receptor action in breast cancerAli, S; Periyasamy, M; Patel, H; Lai, C-F; Nguyen, VTM, et al
14-Jun-2016Expression of CDK7, cyclin H and MAT1 is elevated in breast cancer and is prognostic in estrogen receptor positive breast cancerPatel, H; Abduljabbar, R; Chun-Fui, L; Periyasamy, M; Harrod, A, et al
16-Aug-2017p53 controls expression of the DNA deaminase APOBEC3B to limit its potential mutagenic activity in cancer cellsPeriyasamy, M; Singh, A; Gemma, C; Kranjec, C; Farzan, R, et al
6-Aug-2019Author Correction: Differential epigenetic reprogramming in response to specific endocrine therapies promotes cholesterol biosynthesis and cellular invasionNguyen, VTM; Barozzi, I; Faronato, M; Lombardo, Y; Steel, JH, et al